搜索
[8]BergoGW,TyssebotnI.Cerebralbloodflowdistributionduringexposureto5baroxygeninawakerats[J].UnderseaBiomedRes,1992,19(5):339-354.[9]OmaeT,IbayashiS,KusudaK,etal.Effectsofhighatmosphericpressureandoxygenonmiddlecerebralbloodflowvelocityinhu2mansmeasuredbytranscranialDoppler[J].Stroke,1998,29(1):94-97.[10]ChavkoM,BraistedJC,OutsaNJ,etal.Roleofcerebralbloodflowinseizuresfromhyperbaricoxygenexposure[J].BrainRes,1998,791:75-82.[11]IkramME,MiltonJA,ParuchuriVP,etal.Effectofhyperbaricoxygentreatmentonnitricoxideandoxygenfreeradicalsinratbrain[J].JNeurophysiol,2000,83:2022-2029.[12]BittermanN,BittermanH.L-Arginine-NopathwayandCNSoxygentoxicity[J].JApplPhysiol,1998,84(5):1633-1638.[13]DawsonVL,DawsonTM,LondonED,etal.Nitricoxideme2diatesglutamateneurotoxicityinprimarycorticalcultures[J].ProcNatlAcadSci,1991,88(14):6368-6371.[14]..[M].:,2001.140-146.[15]StadlerJ,BilliarTR,CurranRD,etal.Effectofexogenousandendogenousnitricoxideonmitochondrialrespirationofrathepatocytes[J].AmJPhysiol,1991,260(5Pt1):910-916.[16]LawrenceAJ,JarrottB.Nitricoxideincreasesinterstitialexcitatoryaminoacidreleaseintheratdorsomedialmedullaoblongata[J].NeurosciLett,1993,151(2):126-129.[17]ZhangJ,SuY,OuryTd,etal.Cerebralaminoacid,nore2pinephrineandnitricoxidemetabolisminCNSoxygentoxicity[J].BrainRes,1993,606(1):56-62.[18]ArieliR.Latencyofoxygentoxicityofthecentralnervoussys2teminratsasafunctionofcarbondioxideproductionandpartialpressureofoxygen[J].EurJApplPhysiolOccupPhysiol,1998,78(5):454-459.[19]BittermanN,LaorA,MelamedY.CNSoxygentoxicityinoxy2geninertgasmixtures[J].UnderseaBiomedRes,1987,14(6):477-483.[20]ArieliR,ErtrachtO,OsterI,etal.Effectsofnitrogenandhe2liumonCNSoxygentoxicityintherat[J].ApplPhysiol,2005,98(1):144-150.(:2006-12-26)(:)1,1,2(1.,200433;2.,100841)[];;;[]R285[]A[]1009-0754(2007)02-0179-03,,,,,,1,;;;;,,,,,,,,,,(),,22.1(viralencephalitis,VE),,,[1],13,97120076282JournalofNavyMedicine2007Jun.Vol.28,No.2©1994-2008ChinaAcademicJournalElectronicPublishingHouse.Allrightsreserved.[2],1,1,,2.3,,[3],,,,,2/d,35d24h12,35%,48h8,24%,72h6,17%,8,24%2.4,,20%30%,[4][5],1/,2/d,7d,2.5,:[6]2/d,10.5,;,102.6[7]25,10,40.0%,12,48.0%,3,12.0%,88.0%,,,,1,50ml,,,24h12.7,[8],31/6,31/3,3/d,,48,1,98%2.8,,,,,,[9]150,1/d,1,2d,5d,98,29,20,3,98%2.9,,,,[10],[11][12]36,()1,2/d,5d16,28,(PVS)2,62.10,[13]3[14],,(merouricsulfide),,86.2%,13.8%,,,,,,,,,,,,,,4,,,,,[][1].[J].,2006,28(6):33.[2].[J].,2003,11(3):47.[3],,,.34[J].,2005,27(1):13-14.08120076282JournalofNavyMedicine2007Jun.Vol.28,No.2©1994-2008ChinaAcademicJournalElectronicPublishingHouse.Allrightsreserved.[4].[M].,2002.109-110.[5],.[J].,2005,4(11):1045-1047.[6].1[J].,2003,12(7):752.[7].25[J].,2005,16(1):10.[8].[J].,2004,2(4):39-40.[9],.[J].,2002,10(11):6.[10],.56[J].,1999,15(1):9.[11]DonaldW,PeterBL.Managementofintracranialdypertention[J].CotemporaryNeurosurgery,1997,19(1):534.[12],,,.68[J].,2006,9(10):1099.[13],,.[J].2001,33(12):65.[14],,.[J].,2005,9(34):35.(:2007-02-14)(:),(,810000)[];;[]R25[]A[]1009-0754(2007)02-0181-03,,,,,,,IgEI,,11.1,[1],,,,;;;;cAMP,1.2[2],IgEI:,(PCA),1.3[3]PCA,PCA,IgE,,,,,,H11.4[4],5-HT,,,1.5,[5],PCA1.611:,PCA,,SRS-A[6]1.7,:PCA,[7],I18120076282JournalofNavyMedicine2007Jun.Vol.28,No.2©1994-2008ChinaAcademicJournalElectronicPublishingHouse.Allrightsreserved.